Latham helps Actavis with $25 billion acquisition
Latham & Watkins LLP represented Dublin-based generics drugmaker Actavis PLC in the company's $25 billion acquisition of Forest Laboratories Inc., a pharmaceutical developer headquartered in New York.
Costa Mesa partners R. Scott Shean and Charles K. Ruck co-led the Latham team alongside New York partner Stephen B. Amdur. The team also include...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In